BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome |
| |
| Authors: | Petra Gorombei,Fabien Guidez,Saravanan Ganesan,Mathieu Chiquet,Andrea Pellagatti,Laure Goursaud,Nilgun Tekin,Stephanie Beurlet,Satyananda Patel,Laura Guerenne,Carole Le Pogam,Niclas Setterblad,Pierre de la Grange,Christophe LeBoeuf,Anne Janin,Maria-Elena Noguera,Laure Sarda-Mantel,Pascale Merlet,Jacqueline Boultwood,Marina Konopleva,Michael Andreeff,Robert West,Marika Pla,Lionel Adè s,Pierre Fenaux,Patricia Krief,Christine Chomienne,Nader Omidvar,Rose Ann Padua |
| |
| Abstract: | |
| |
| Keywords: | HR-MDS BCL-2 ABT-737 gene regulation |
|
|
